ncRNA name
hsa-miR-625-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
MAP2K6-p38
Cancer name
Colorectal Adenocarcinoma
Cancer site
Colon, Rectum, and Anus
Treatment type
Chemotherapy
Drug
Oxaliplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Ectopic expression of miR-625-3p promotes Oxaliplatin resistance.
Tissue resource
primary colorectal cancer biopsies
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Departments of Odense University Hospital and Aarhus University Hospital
Country
Denmark
Continent
Europea